Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with <i>Diabetes mellitus</i>

Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with <i>Diabetes mellitus</i>

Purpose: To determine the efficacy of systemic sodium-glucose co-transporter 2 inhibitors (SGLT2i) on diabetic macular edema (DME). Methods: The medical records of patients with DME with a central retinal thickness (CRT) ≥320 µm in men and 305 µm in women, more than 6 months after the initiation of...

Full description

Bibliographic Details
Main Authors: Tomoaki Tatsumi, Toshiyuki Oshitari, Yoko Takatsuna, Ryoichi Ishibashi, Masaya Koshizaka, Yuki Shiko, Takayuki Baba, Koutaro Yokote, Shuichi Yamamoto
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Life
Subjects:
aflibercept
anti-VEGF
diabetic macular edema
sodium-glucose co-transporter 2 inhibitors
SGLT2
Online Access:https://www.mdpi.com/2075-1729/12/5/692

Internet

https://www.mdpi.com/2075-1729/12/5/692

Similar Items